期刊文献+

丙氨酸转氨酶显著升高的药物性肝损伤的临床特点分析 被引量:2

ANALYSIS OF CLINICAL CHARACTERISTICS OF PATIENTS IN DRUG-INDUCED LIVER INJURY WITH SIGNIFICANTLY INCREASED ALANINE AMINOTRANSFERASE
原文传递
导出
摘要 目的研究丙氨酸转氨酶(ALT)明显增高的药物性肝损伤(DILI)临床特点,以期正确治疗及准确判断预后。方法收集2013年2月—2015年8月就诊于河南省人民医院的ALT大于10倍正常上限(10ULN)的DILI患者的数据资料共300例,对资料完整的277例数据进行回顾性分析。结果277例DILI患者平均年龄(40.3±18.7)岁,男性︰女性为1.5︰1。ALT>10ULN的DILI患者中肝细胞型占比最多(65.7%),肝细胞型、混合型和胆汁淤积型患者治愈好转率分别是85.2%、91.0%、52.9%,胆汁淤积型与二者相比治愈好转率较低(P<0.05)。1级(轻度肝损伤)比2级(中度肝损伤)、3级(重度肝损伤)、4级(ALF)患者的ALT平均值低(P<0.05)。引起DILI的药物最常见为传统中药(TCM),其余为抗肿瘤药和抗感染药等。结论TCM、抗肿瘤药与抗感染药是引起DILI的主要原因;DILI患者男性多见,以肝细胞型居多,肝细胞型和混合型预后比较好。 Objective To study the clinical characteristics of patients in drug-induced liver injury(DILI)with significantly increased alanine aminotransferase(ALT),so as to correctly treat and accurately judge the prognosis.Methods A total of three hundred patients with DILI with ALT levels above 10 times upper limit of normal range(10 ULN)from February 2013 to August 2015 were retrieved,and 277 cases with complete clinical data were collected and analyzed retrospectively.Results The average age of 277 DILI patients with complete data was 40.3±18.7 years old,and the male to female ratio is 1.5︰1.Hepatocellular injury accounted for the largest proportion(65.7%).The prognosis of hepatocellular type,mixed type,cholestasis type was 85.2%,91.0%,52.9%.The prognosis of cholestasis type is lower(P<0.05).Level 1(Mild liver injury)in the mean ALT level is lower than level 2(moderate liver injury),level 3(severe liver injury),level 4(ALF)(P<0.05).The most common drug causing DILI is TCM,followed by antineoplastic drugs and anti-infective agents.Conclusion TCM,antineoplastic drugs,anti infective drugs may be the main causes of DILI in China.DILI patients are predominantly male,and most patients were hepatocellular.Prognosis of hepatocellular type and mixed type is relatively good.
作者 郑丽娜 丁辉 朱武凌 韩双印 ZHENG Lina;DING Hui;ZHU Wuling;HAN Shuangyin(Xinxiang Medical University,Xinxiang 453000,China)
出处 《中国煤炭工业医学杂志》 2021年第4期441-444,共4页 Chinese Journal of Coal Industry Medicine
基金 河南省科技厅项目(编号:132102310444)。
关键词 药物性肝损伤 肝酶 丙氨酸转氨酶 Drug-induced liver injury liverenzyme Alanine aminotransferase
  • 相关文献

参考文献4

二级参考文献88

  • 1张琼华,施光峰,李谦,陈明泉.甘草酸二铵肠溶胶囊治疗慢性肝炎2396例[J].中华传染病杂志,2007,25(3):175-176. 被引量:16
  • 2E.Pukenyte,F.X.Lescure,D.Rey,C.Rabaud,B.Hoen,P.Chavanet,A.P.Laiskonis,J.L.Schmit,T.May,Y.Mouton,Y.Yazdanpanah,马玙,张立兴.HIV感染者抗结核治疗过程中严重肝毒性反应的发生率及其危险因素[J].国际结核病与肺部疾病杂志,2007,2(1):30-35. 被引量:13
  • 3[1]Clark JM,Brancati FL,Diehl AM.Nonalcoholic fatty liver disease.Gastroenterology 2002; 122:1649-1657
  • 4[2]Franzese A,Vajro P,Argenziano A,Puzziello A,Iannucci MP,Saviano MC,Brunetti F,Rubino A.Liver involvement in obese children.Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population.Dig Dis Sci 1997; 42:1428-1432
  • 5[3]Tominaga K,Kurata JH,Chen YK,Fujimoto E,Miyagawa S,Abe 1,Kusano Y.Prevalence of fatty liver in Japanese children and relationship to obesity.An epidemiological ultrasonographic survey.Dig Dis Sci 1995; 40:2002-2009
  • 6[4]Browning JD,Szczepaniak LS,Dobbins R,Nuremberg P,Horton JD,Cohen JC,Grundy SM,Hobbs HH.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity.Hepatology 2004; 40:1387-1395
  • 7[5]Neuschwander-Tetri BA.Nonalcoholic steatohepatitis and the metabolic syndrome.Am J Med Sci 2005; 330:326-335
  • 8[6]Adams LA,Lymp JF,St Sauver J,Sanderson SO,Lindor KD,Feldstein A,Angulo P.The natural history of nonalcoholic fatty liver disease:a population-based cohort study.Gastroenterology 2005; 129:113-121
  • 9[7]Browning JD,Horton JD.Molecular mediators of hepatic steatosis and liver injury.J Clin Invest 2004; 114:147-152
  • 10[8]Machado M,Cortez-Pinto H.Non-alcoholic steatohepatitis and metabolic syndrome.Curr Opin Clin Nutr Metab Care 2006; 9:637-642

共引文献587

同被引文献29

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部